Renewable Solvents
The pharma decarbonization challenge
Solvents account for 80–90% of process mass in API manufacturing. Safion’s proprietary catalytic platform converts renewable feedstocks into ultra-high-purity acetonitrile with approximately 90% lower carbon intensity than fossil-derived acetonitrile. It addresses rapidly growing oligonucleotide demand while creating a material Scope 3 reduction lever for pharmaceutical manufacturers.
Explore Renewable Solvents →